Mieloma, amiloidosi, macroglobulinèmia i altres gammapaties
Publicacions destacades
-
Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia
Moreno DF; López-Guerra M; Paz S; Oliver-Caldés A; Mena MP;(...)Jiménez-Segura R; Bladé J; Rosiñol L; Colomer D; Fernández de Larrea C .Referència:British Journal Of Haematology 2023.
-
T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells
Battram, AM; Oliver-Caldés, A; Suárez-Lledó, M; Lozano, M; Crespo, MBI;(...)Cid, J; Moreno, DF; Rodríguez-Lobato, LG; Urbano-Ispizua, A; de Larrea, CF.Referència:Molecular Therapy-Methods & Clinical Development 2022.
-
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
De Larrea, CF; Kyle, R; Rosiñol, L; Paiva, B; Engelhardt, M;(...)Kaiser, M; San Miguel, J; Bladé, J; Rajkumar, SV; Mateos, MV.Referència:Blood Cancer Journal 2021.
-
Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease
Isola, I; Brasó-Maristany, F; Moreno, DF; Mena, MP; Oliver-Calders, A;(...)Bladé, J; Rosiñol, L; Prat, A; Lozano, E; de Larrea, CF.Referència:Frontiers In Immunology 2021.
-
Treatment of Patients with Monoclonal Gammopathy of Clinical Significance
Moreno, DF; Rosiñol, L; Cibeira, MT; Bladé, J; de Larrea, CF;Referència:Cancers 2021.
-
Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy
Moreno, DF; Pereira, A; Tovar, N; Cibeira, MT; Magnano, L;(...)Oliver-Caldés, A; Mena, MP; Rosiñol, L; Bladé, J; de Larrea, CF.Referència:Cancers 2021.
-
Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure
Uribe-Herranz, Mireia; Klein-Gonzalez, Nela; Rodriguez-Lobato, Luis Gerardo; Juan, Manel; Fernandez de Larrea, Carlos;Referència:International Journal Of Molecular Sciences 2021.
-
Nectin-2 expression on malignant plasma cells is associated with better response to TIGIT blockade in multiple myeloma
Lozano E; Mena MP; Díaz T; Martin-Antonio B; León S;(...)Cibeira MT; Bladé J; Prat A; Rosiñol L; Fernández de Larrea C .Referència:Clinical Cancer Research 2020.
-
Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression
Fernandez de Larrea, Carlos; Isola, Ignacio; Pereira, Arturo; Teresa Cibeira, Ma; Magnano, Laura;(...)Lozano, Ester; Rozman, Maria; Yague, Jordi; Blade, Joan; Rosinol, Laura;.Referència:Leukemia 2018.
-
Bone marrow plasma cell infiltration in light chain amyloidosis: impact on organ involvement and outcome.
Tovar N; Rodríguez-Lobato LG; Cibeira MT; Magnano L; Isola I;Rosiñol L; Bladé J; Fernández de Larrea C .Referència:Amyloid-Journal Of Protein Folding Disorders 2018.